Literature DB >> 19038785

Early pulmonary cytokine and chemokine responses in mice immunized with three different vaccines against Mycobacterium tuberculosis determined by PCR array.

JaeHyun Lim1, Steven C Derrick, Kristopher Kolibab, Amy Li Yang, Steven Porcelli, William R Jacobs, Sheldon L Morris.   

Abstract

In this study, the early pulmonary cytokine and chemokine responses in mice immunized with either BCG vaccine, a DeltasecA2 mutant of Mycobacterium tuberculosis, or a DNA vaccine expressing an ESAT6-antigen 85B fusion protein and then aerogenically challenged with a low dose of M. tuberculosis were evaluated by PCR array. The cellular immune responses at day 10 postchallenge were essentially equivalent in the lungs of mice immunized with either the highly immunogenic BCG vaccine or the DeltasecA2 M. tuberculosis mutant strain. Specifically, 12 immune biomolecules (including gamma interferon [IFN-gamma], interleukin-21 [IL-21], IL-27, IL-17f, CXCL9, CXCL10, and CXCL11) were differentially regulated, relative to the levels for naïve controls, in the lungs of vaccinated mice at this time point. Although the vaccine-related immune responses evoked in mice immunized with the DNA vaccine were relatively limited at 10 days postinfection, upregulation of IFN-gamma RNA synthesis as well as increased expression levels of CXCL9, CXCL10, and CXCL11 chemokines were detected.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19038785      PMCID: PMC2620659          DOI: 10.1128/CVI.00359-08

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  28 in total

1.  Cutting edge: IFN-inducible ELR- CXC chemokines display defensin-like antimicrobial activity.

Authors:  A M Cole; T Ganz; A M Liese; M D Burdick; L Liu; R M Strieter
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

2.  A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity.

Authors:  Steven C Derrick; Amy Li Yang; Sheldon L Morris
Journal:  Vaccine       Date:  2004-12-21       Impact factor: 3.641

3.  IL-27 signaling compromises control of bacterial growth in mycobacteria-infected mice.

Authors:  John E Pearl; Shabaana A Khader; Alejandra Solache; Leigh Gilmartin; Nico Ghilardi; Fred deSauvage; Andrea M Cooper
Journal:  J Immunol       Date:  2004-12-15       Impact factor: 5.422

Review 4.  New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions.

Authors:  Christopher A Hunter
Journal:  Nat Rev Immunol       Date:  2005-07       Impact factor: 53.106

Review 5.  Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria.

Authors:  T H Ottenhoff; D Kumararatne; J L Casanova
Journal:  Immunol Today       Date:  1998-11

6.  DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis.

Authors:  Giovanni Delogu; Amy Li; Charlene Repique; Frank Collins; Sheldon L Morris
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

7.  Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature.

Authors:  G A Colditz; T F Brewer; C S Berkey; M E Wilson; E Burdick; H V Fineberg; F Mosteller
Journal:  JAMA       Date:  1994-03-02       Impact factor: 56.272

8.  Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways.

Authors:  M Laan; Z H Cui; H Hoshino; J Lötvall; M Sjöstrand; D C Gruenert; B E Skoogh; A Lindén
Journal:  J Immunol       Date:  1999-02-15       Impact factor: 5.422

9.  Chemokine response in mice infected with Mycobacterium tuberculosis.

Authors:  E R Rhoades; A M Cooper; I M Orme
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

Review 10.  Immunology of tuberculosis and implications in vaccine development.

Authors:  JoAnne L Flynn
Journal:  Tuberculosis (Edinb)       Date:  2004       Impact factor: 3.131

View more
  13 in total

1.  Transcriptional suppression of IL-27 production by Mycobacterium tuberculosis-activated p38 MAPK via inhibition of AP-1 binding.

Authors:  Jidong Zhang; Xuesong Qian; Huan Ning; Christopher S Eickhoff; Daniel F Hoft; Jianguo Liu
Journal:  J Immunol       Date:  2011-04-11       Impact factor: 5.422

2.  Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant.

Authors:  Kristopher Kolibab; Amy Yang; Steven C Derrick; Thomas A Waldmann; Liyanage P Perera; Sheldon L Morris
Journal:  Clin Vaccine Immunol       Date:  2010-03-31

3.  Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites.

Authors:  Isaac G Sakala; Lars Kjer-Nielsen; Christopher S Eickhoff; Xiaoli Wang; Azra Blazevic; Ligong Liu; David P Fairlie; Jamie Rossjohn; James McCluskey; Daved H Fremont; Ted H Hansen; Daniel F Hoft
Journal:  J Immunol       Date:  2015-06-10       Impact factor: 5.422

4.  Mycobacterium bovis-BCG vaccination induces specific pulmonary transcriptome biosignatures in mice.

Authors:  Elihu Aranday Cortes; Daryan Kaveh; Javier Nunez-Garcia; Philip J Hogarth; H Martin Vordermeier
Journal:  PLoS One       Date:  2010-06-28       Impact factor: 3.240

5.  Development of a murine mycobacterial growth inhibition assay for evaluating vaccines against Mycobacterium tuberculosis.

Authors:  Marcela Parra; Amy L Yang; JaeHyun Lim; Kristopher Kolibab; Steven Derrick; Nathalie Cadieux; Liyanage P Perera; William R Jacobs; Michael Brennan; Sheldon L Morris
Journal:  Clin Vaccine Immunol       Date:  2009-05-20

6.  Development of an unbiased antigen-mining approach to identify novel vaccine antigens and diagnostic reagents for bovine tuberculosis.

Authors:  Gareth J Jones; Bhagwati L Khatri; M Carmen Garcia-Pelayo; Daryan A Kaveh; Véronique S Bachy; Philip J Hogarth; Esen Wooff; Paul Golby; H Martin Vordermeier
Journal:  Clin Vaccine Immunol       Date:  2013-08-28

7.  Correlates of Vaccine-Induced Protection against Mycobacterium tuberculosis Revealed in Comparative Analyses of Lymphocyte Populations.

Authors:  Sherry L Kurtz; Karen L Elkins
Journal:  Clin Vaccine Immunol       Date:  2015-08-12

8.  Induction of Unconventional T Cells by a Mutant Mycobacterium bovis BCG Strain Formulated in Cationic Liposomes Correlates with Protection against Mycobacterium tuberculosis Infections of Immunocompromised Mice.

Authors:  Steven C Derrick; Idalia Yabe; Sheldon Morris; Siobhan Cowley
Journal:  Clin Vaccine Immunol       Date:  2016-07-05

9.  Systemic BCG immunization induces persistent lung mucosal multifunctional CD4 T(EM) cells which expand following virulent mycobacterial challenge.

Authors:  Daryan A Kaveh; Véronique S Bachy; R Glyn Hewinson; Philip J Hogarth
Journal:  PLoS One       Date:  2011-06-24       Impact factor: 3.240

10.  Molecular analysis of non-specific protection against murine malaria induced by BCG vaccination.

Authors:  Marcela Parra; Xia Liu; Steven C Derrick; Amy Yang; Jinhua Tian; Kristopher Kolibab; Sanjai Kumar; Sheldon L Morris
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.